These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10270312)
1. Cost containment through therapeutic substitution of aminoglycosides. Guernsey BG; Berina LF; Lazarus MC; Hokanson JA; Prohaska C; Allen JA; Doutre WH; Mader JT Hosp Pharm; 1985 Feb; 20(2):82-3, 86-92, 95. PubMed ID: 10270312 [TBL] [Abstract][Full Text] [Related]
2. The effect of pharmacy intervention on aminoglycoside costs. Tsuyuki RT; Nakagawa RS Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090 [TBL] [Abstract][Full Text] [Related]
3. Cost-benefit analysis of an aminoglycoside monitoring service. Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162 [TBL] [Abstract][Full Text] [Related]
4. Effect of aminoglycoside-use restrictions on drug cost. DeTorres OH; White RE Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070 [TBL] [Abstract][Full Text] [Related]
5. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Hayman JN; Sbravati EC Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250 [TBL] [Abstract][Full Text] [Related]
6. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy. Possidente CJ; Lynch T Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757 [TBL] [Abstract][Full Text] [Related]
7. A strategy to reduce drug expenditures with a drug utilization review program. Hoffmann RP Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746 [TBL] [Abstract][Full Text] [Related]
8. Financial impact of an aminoglycoside substitution program. Andrews JD; Stad K Can J Hosp Pharm; 1987 Feb; 40(1):23-6. PubMed ID: 10281256 [TBL] [Abstract][Full Text] [Related]
9. Prospective audit of an aminoglycoside consultative service in a general hospital. Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470 [TBL] [Abstract][Full Text] [Related]
10. Cost savings associated with use of gentamicin versus tobramycin. Schwinghammer TL; Romano MJ; Wing EJ Am J Hosp Pharm; 1985 Aug; 42(8):1745-9. PubMed ID: 4036972 [TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing. Khanderia U Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722 [TBL] [Abstract][Full Text] [Related]
12. Cost containment through P & T committee drug utilization review. Bender FH; DeMatteo CS Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391 [TBL] [Abstract][Full Text] [Related]
13. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary. Cramer R; Wright C Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858 [TBL] [Abstract][Full Text] [Related]
15. Impact of an aminoglycoside kinetic service on aminoglycoside use in a community hospital. Cahill RJ; Myers RM; Bauer LA; Alston RM Hosp Pharm; 1986 Aug; 21(8):734-7. PubMed ID: 10277582 [TBL] [Abstract][Full Text] [Related]
16. Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital. Leong CL; Buising K; Richards M; Robertson M; Street A Intern Med J; 2006 Jan; 36(1):37-42. PubMed ID: 16409311 [TBL] [Abstract][Full Text] [Related]
17. Justification and evaluation of an aminoglycoside pharmacokinetic dosing service. Jorgenson JA; Rewers RF Hosp Pharm; 1991 Jul; 26(7):605, 609-11, 615. PubMed ID: 10111793 [TBL] [Abstract][Full Text] [Related]
18. Cefoxitin use review. Lazor-Bajcar JM Can J Hosp Pharm; 1990 Oct; 43(5):221-5, xxxii. PubMed ID: 10107924 [TBL] [Abstract][Full Text] [Related]
19. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
20. Compliance with guidelines for monitoring aminoglycoside therapy. Sketris IS; Parker WA; Noble MA Can J Hosp Pharm; 1982; 35(6):179-83. PubMed ID: 10262190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]